| Entry |
|
|---|
| Name |
Rimantadine (INN) |
|---|
| Formula |
C12H21N
|
|---|
| Exact mass |
179.1674
|
|---|
| Mol weight |
179.30
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antiviral
DG03029 Anti-influenza virus agent
DG02841 Viral uncoating inhibitor
|
|---|
| Remark |
| Product (DG00650): | D00901<US> |
|
|---|
| Efficacy |
Antiviral, M2 protein inhibitor |
|---|
| Comment |
Adamantane derivative
|
|---|
| Target |
Influenza A virus M2 [KO: K19394] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AC Cyclic amines
J05AC02 Rimantadine
D08483 Rimantadine (INN)
Drug groups [BR:br08330]
Antiviral
DG03029 Anti-influenza virus agent
DG02841 Viral uncoating inhibitor
DG00650 Rimantadine
D08483 Rimantadine
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
Influenza virus uncoating inhibitor
D08483 Rimantadine (INN)
Drug groups [BR:br08330]
Antiviral
DG03029 Anti-influenza virus agent
DG02841 Viral uncoating inhibitor
DG00650 Rimantadine
Antimicrobials abbreviations [BR:br08327]
Antivirals
Entry, fusion or uncoating inhibitor
Influenza virus uncoating inhibitor
DG00650 Rimantadine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 13
1 C1z C 24.7800 -17.0100
2 C1c C 24.7800 -15.8200
3 C1x C 24.1500 -18.5500
4 C1x C 23.7300 -17.6400
5 C1x C 25.9000 -17.6400
6 C1a C 23.7300 -15.1900
7 N1a N 25.9000 -15.1900
8 C1y C 24.1500 -19.6700
9 C1y C 23.7300 -18.9000
10 C1y C 25.9000 -18.9000
11 C1x C 22.4700 -20.1600
12 C1x C 25.3400 -20.7200
13 C1x C 24.7800 -19.4600
BOND 15
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1
5 2 6 1
6 2 7 1
7 3 8 1
8 4 9 1
9 5 10 1
10 8 11 1
11 8 12 1
12 9 13 1
13 9 11 1
14 10 12 1
15 10 13 1
|
|---|
